Your session is about to expire
← Back to Search
Stannous Fluoride Toothpaste for Tooth Sensitivity
Study Summary
This trial will evaluate how a special toothpaste helps people with sensitive teeth to improve their oral health and quality of life.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2016 Phase 4 trial • 197 Patients • NCT02923895Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can those aged 75 years or older participate in this clinical study?
"This clinical trial has specified that participants must range from 18 to 65 years old. For those younger and older, respectively, there are 89 trials for minors and 177 studies catering specifically to seniors."
How many test subjects are presently enrolled in this research project?
"Affirmative. According to clinicaltrials.gov, this research initiative is still searching for participants and was initially published on September 21st 2023 with the latest update issued October 6th of the same year. This trial requires 500 individuals from a single medical centre."
Are there any vacancies left in this clinical trial?
"Affirmative. Clinicaltrials.gov states that this clinical trial, which was posted on September 21st 2023, is currently looking for 500 participants at 1 site. The details have been updated as of October 6th 2023."
Am I eligible to participate in this scientific experiment?
"This medical trial is enrolling 500 volunteers aged between 18 and 65 who suffer from tooth sensitivity. To be eligible, participants must willingly give consent for the study, have the capacity to complete tasks on their own with smart devices, as well as attest to experiencing symptoms of tooth discomfort."
What are the key goals of this research endeavor?
"The primary objective for this medical trial, which will be evaluated at Baseline and Weeks 4, 8, 12, 16, 20 & 24 is to assess the transformation in DHEQ Identity Domain (Q30-34) Score. Secondary goals include monitoring change from baseline with regards to Numeric Pain Rating Scale (NPRS) outcomes at Weeks 1, 2 ,4 ,8 ,12 ,16,,20 & 24; Satisfaction Numeric Rating Scale (NRS) Score at Week 24; and Global Oral Health (Section 2 Q35) score during the same intervals."
Share this study with friends
Copy Link
Messenger